Exane Derivatives’s TD Synnex SNX Stock Holding History

Exane Derivatives’s Portfolio SNX Stock Details SNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9,161	Closed	-$945K	–	899
2022 Q1	$945K	Buy	+9,161	New	+$974K	0.27%	101

Other funds holding SNX

AMH

Apollo Management Holdings New York $8.94B AUM 120.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.05B AUM 71.03% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Exane Derivatives's SNX Position: Q2 2022 in Review

Exane Derivatives sold out of TD Synnex (SNX) in Q2 2022, closing a stake of 9,161 shares — an estimated $945K sold.

Exane Derivatives first reported a position in SNX in Q1 2022 and held it in 1 quarter. The position peaked at $945K in Q1 2022. 328 funds tracked by Wall St. Rank hold SNX as of Q2 2022.

Exane Derivatives reported no remaining TD Synnex position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 9,161 TD Synnex shares in Q2 2022, an estimated $945K.
Exane Derivatives first reported a position in TD Synnex in Q1 2022 and held it in 1 quarter.
Exane Derivatives's TD Synnex position peaked at $945K in Q1 2022.
328 funds tracked by Wall St. Rank held TD Synnex as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.